Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney

Kidney International

Volumn 61, Issue 5, 2002, Pages 1760-1768

  Deguchi, Tsuneo ^a,b,c   Ohtsuki, Sumio ^a,b,c   Otagiri, Masaki ^a,b,c   Takanaga, Hitomi ^a,b,c   Asaba, Hiroshi ^a,b,c   Mori, Shinobu ^a,b,c   Terasaki, Tetsuya ^a,b,c  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c CREST of the Japan Science and Technology Corporation   (Japan)

Author keywords

Chronic renal failure; Indoxyl sulfate; Nephrotoxicity; Organic anion transporter 3; Renal disease; Uremia; Uremic toxin

Indexed keywords

4 AMINOHIPPURIC ACID; CARRIER PROTEIN; CIMETIDINE; HIPPURIC ACID; INDICAN; INDOLEACETIC ACID; INDOMETACIN; LIOTHYRONINE; ORGANIC ANION TRANSPORTER 3; PENICILLIN G; PROBENECID; PROPIONIC ACID DERIVATIVE; SALICYLIC ACID; UNCLASSIFIED DRUG; UREMIC TOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANION TRANSPORT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; INHIBITION KINETICS; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; MALE; NEPHROTOXICITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT; UREMIA; URINARY EXCRETION; XENOPUS LAEVIS;

EID: 0036233041     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00318.x     Document Type: Article

References (42)

1. Studies on the pathogenesis of uremia. Comparative determinations of glucuronic acid, indican, free and bound phenols in the serum, cerebrospinal fluid, and urine of renal diseases with and without uremia
2. Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography
3. Characterization of binding site of uremic toxins on human serum albumin
4. Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid
5. Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin
6. Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure
7. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis
8. Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate
9. Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys
10. Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure
11. Mechanism of stereoselective serum binding of ketoprofen after hemodialysis
12. Uricosuric agents in uremic sera. Identification of indoxyl sulfate and hippuric acid
13. Expression cloning and characterization of a novel multispecific organic anion transporter
14. Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney
15. Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney
16. Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney
17. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver
18. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain
19. The multispecific organic anion transporter (OAT) family
20. Cellular and molecular aspects of drug transport in the kidney
21. Maintenance of Xenopus laevis and oocyte injection
22. In vivo evidence for carrier-mediated uptake of beta-lactam antibiotics through organic anion transport systems in rat kidney and liver
23. Selective availability of protein bound estrogen and estrogen conjugates to the rat kidney
24. Influence of blood components on the tissue uptake indices of cyclosporin in rats
25. A pharmacokinetic analysis program (multi) for microcomputer
26. Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3
27. Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes
28. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2
29. Plasma clearance in the rat of a furan dicarboxylic acid which accumulates in uremia
30. Renal organic acid transport: Uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia
31. Organic acids and the uremic syndrome: Protein metabolite hypothesis in the progression of chronic renal failure
32. Lost mass and excretion as stimuli to parabiotic compensatory renal hypertrophy
33. Circulatory retention of urinary factors as a stimulus to renal growth
34. Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis
35. The progression of renal disease
36. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney
37. Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney
38. Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney
39. Mrna distribution and membrane localization of the OAT-K 1 organic anion transporter in rat renal tubules
40. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease
41. Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: A quantitative analysis
42. The protein metabolite hypothesis, a model for the progression of renal failure: An oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients